BioCentury
ARTICLE | Company News

Antigenics, Aronex deal

July 16, 2001 7:00 AM UTC

AGEN completed its previously announced acquisition of ARNX (see BioCentury, April 30). ARNX shareholders will receive 0.0594 AGEN shares for each ARNX share held, and may receive up to an additional ...